Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita. | Hum Pathol (N Y) | 2021 | 34522616 | PubTator, text mining | PubMed |
| Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. | Nat Commun | 2021 | 34518531 | PubTator, text mining | PubMed |
| Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). | PLoS One | 2021 | 34506616 | PubTator, text mining | PubMed |
| TAZ maintains telomere length in TNBC cells by mediating Rad51C expression. | Breast Cancer Res | 2021 | 34488828 | PubTator, text mining | PubMed |
| Integrated evaluation of telomerase activation and telomere maintenance across cancer cell lines. | Elife | 2021 | 34486523 | PubTator, text mining | PubMed |
| H2AFZ: A Novel Prognostic Marker in Canine Melanoma and a Predictive Marker for Resistance to CDK4/6 Inhibitor Treatment. | Front Vet Sci | 2021 | 34485433 | PubTator, text mining | PubMed |
| The Paradoxical Role of Cellular Senescence in Cancer. | Front Cell Dev Biol | 2021 | 34458273 | PubTator, text mining | PubMed |
| Regulation of Antigenic Variation by Trypanosoma brucei Telomere Proteins Depends on Their Unique DNA Binding Activities. | Pathogens | 2021 | 34451431 | PubTator, text mining | PubMed |
| Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data | Turk J Haematol | 2021 | 34448556 | PubTator, text mining | PubMed |
| Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management. | J Clin Med | 2021 | 34442055 | PubTator, text mining | PubMed |
| Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin. | Genes (Basel) | 2021 | 34440462 | PubTator, text mining | PubMed |
| Exosomes and Micro-RNAs in Aging Process. | Biomedicines | 2021 | 34440172 | PubTator, text mining | PubMed |
| NF-κB in Gastric Cancer Development and Therapy. | Biomedicines | 2021 | 34440074 | PubTator, text mining | PubMed |
| The makings of TERRA R-loops at chromosome ends. | Cell Cycle | 2021 | 34432566 | PubTator, text mining | PubMed |
| Structure, dynamics, and regulation of TRF1-TIN2-mediated trans- and cis-interactions on telomeric DNA. | J Biol Chem | 2021 | 34403696 | PubTator, text mining | PubMed |
| Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer. | Signal Transduct Target Ther | 2021 | 34400610 | PubTator, text mining | PubMed |
| PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis. | Front Med (Lausanne) | 2021 | 34386506 | PubTator, text mining | PubMed |
| Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). | J Immunother Cancer | 2021 | 34380663 | PubTator, text mining | PubMed |
| How DNA damage and non-canonical nucleotides alter the telomerase catalytic cycle. | DNA Repair (Amst) | 2021 | 34371388 | PubTator, text mining | PubMed |
| Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk. | J Transl Genet Genom | 2021 | 34368645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=38